Thursday, 11.9.2025

0830 - 0835 all rooms	Opening of the SGG-SGVC-SASL-SVEP congress Markus Heim, Basel
0835 - 1000 Auditorium	Endoscopy I - Endoscopic Submucosal Dissection (ESD): Meet the experts [sponsored by Olympus] (simultaneous interpreting into german, french and italian) Peter Bauerfeind, Luzern    Martin Müller, Chur    Reiner Wiest, Bern
0835 - 0915 Auditorium	Case 1 Stefan Seewald and Nursing Team from Hirslanden Zürich, Zürich
0915 - 0955 Auditorium	Case 2 Remus Frei and Nursing Team from H-OCH, St. Gallen
0835 - 1000 Theatersaal	Inflammatory Bowel Diseases Alain Schoepfer, Lausanne
0835 - 0857 Theatersaal	Optimizing Treatment Sequences in IBD Sebastian Zeissig, Greifswald
0857 - 0919 Theatersaal	Anti-IL-23 therapies in IBD: are they all the same? Christoph Högenauer, Graz
0919 - 0942 Theatersaal	IBD therapy in pregnancy Mette Julsgaard, Aarhus
0942 - 1000 Theatersaal	Strategies to break the therapeutic ceiling in IBD Chris Ma, Calgary, Canada
0835 - 1000 Ballsaal	New Challenges in Hepatology Christine Bernsmeier, Basel    Darius Moradpour, Lausanne
0835 - 0857 Ballsaal	Minimal-invasive liver therapies for liver cancer Anja Lachenmayer, Bern
0857 - 0919 Ballsaal	Acute-on-chronic liver failure Julia Wendon, London
0919 - 0942 Ballsaal	Non-invasive assessment of liver disease Annalisa Berzigotti, Bern
0942 - 1000 Ballsaal	Autoimmune hepatitis Maria Carlota Londoño, Barcelona
0835 - 1000 Saal Brünig	SGVC Session I: Limits of oncologic surgery in 2025 Fariba Abbassi, Zürich    Markus Weber, Zürich
0835 - 0857 Saal Brünig	Upper gastrointestinal tract Surgery Stefan Gutknecht, Zürich
0857 - 0919 Saal Brünig	Hepato-Pancreato-Biliary Surgery Alessandra Cristaudi, Lugano
0919 - 0942 Saal Brünig	Endocrine Surgery Reto Kaderli, Bern
0942 - 1000 Saal Brünig	Sarcoma Surgery Alexander Wilhelm, Basel
1000 - 1030 Exhibition Area	Coffee break
1030 - 1200 Auditorium	SGG-SGVC-SASL-SVEP Joint Session - The Obesity Epidemic and Its Impact on Visceral Medicine (simultaneous interpreting into german, french and italian) Markus Heim, Basel    Frank Bieger, Oberwil    Tobias Ehmann, Zofingen    Diana Vetter, Zürich
1030 - 1052 Auditorium	A diabetologists perspective on the obesity epidemic and its impact on visceral medicine Hannele Yiki-Järvinen, Helsinki
1052 - 1114 Auditorium	Treatment of obesity and metabolic disease with gut hormones Michael Nauck, Bochum
1114 - 1136 Auditorium	The 2024 EASL–EASD–EASO guidelines on MASLD Sven Francque, Antwerpen
1136 - 1200 Auditorium	Is there still a place for bariatric surgerys? Styliani Mantziari, Lausanne
1200 - 1330 Exhibition Area	Lunch break
1230 - 1330 Saal Susten	GA Interessengruppe Upper GI SGVC
1215 - 1245 Ballsaal	Lunch symposium Gilead: New HBV EASL Guidelines: Implications for Clinical Practice Andrea De Gottardi, Luzern    Montserrat Fraga, Lausanne
1215 - 1245 Theatersaal	Lunch symposium abbvie: Guardians of the Gut: Timely Interventions in IBD Treatment Luc Biedermann, Zürich    Alain Schoepfer, Lausanne
1250 - 1320 Ballsaal	Lunch symposium Spagyros: Understanding the microbiome: Innovative therapeutic approaches Michael Scharl, Zürich
1250 - 1320 Theatersaal	Lunch symposium Olympus
1330 - 1500 Auditorium	The Evolving Landscape for Gastroenterologists and Hepatologists: Reimbursement, Hygiene, Advanced Practice Nursing and Artificial Intelligence (simultaneous interpreting into german, french and italian) Martin Müller, Chur    Beat Müllhaupt, Zürich    Daniele Riva, Lugano
1330 - 1400 Auditorium	TARDOC: Challenges for private practice gastroenterologists and hospitals Ellen Utzinger, Wallisellen
1400 - 1420 Auditorium	Hygiene and reprocessing of flexible endoscopes : myths, truths, novel swissmedic guidelines…and how to pay for it Alain Vonlaufen, Genève
1420 - 1440 Auditorium	Advanced Practice Nursing: Where can it make a difference for patients? Patrizia Künzler-Heule, St. Gallen    Sonja Beckmann, Zürich
1440 - 1500 Auditorium	ChatGPT and co: How will it change my daily practice? Nicolas Goossens, Genève
1330 - 1500 Theatersaal	IBD oral presentations Luc Biedermann, Zürich    Stephan R. Vavricka, Zürich
1330 - 1355 Theatersaal	Impact of cardiovascular risk factors on IBD treatment Stephan Brand, St. Gallen
1400 - 1410 Theatersaal	The GPR35 Ligand 8-Methoxykynurenate Drives Eosinophilic Esophagitis via IL-18-Mediated Barrier Dysfunction Hassan Melhem, Basel
1410 - 1420 Theatersaal	Acceptability and Tolerance of Risankizumab Treatment Administered via On-Body Injector in Patients with Crohn’s Disease: Results of the Nationwide ACCEPT-OBI Study Pascal Juillerat, Bern and Fribourg
1420 - 1430 Theatersaal	Natural history of eosinophilic esophagitis under anti-inflammatory treatment – The natural history study 2.0 Sofia Asikainen, Lugano
1430 - 1440 Theatersaal	Functional Dynamics of Esophageal Macrophages in Murine Models of Eosinophilic Esophagitis Juening Kang, Basel
1440 - 1450 Theatersaal	Characterization of Rgs14 in inflammatory bowel disease Mao Chen, Basel
1450 - 1500 Theatersaal	XBB.1.5 COVID-19 mRNA vaccines induce inadequate mucosal immunity in immunocompromised patients with inflammatory bowel disease Simon Woelfel, St. Gallen
1330 - 1500 Ballsaal	Hepatology oral presentations I Montserrat Fraga, Lausanne    Magdalena Filipowicz Sinnreich, Basel
1330 - 1355 Ballsaal	Immune dysfunction in liver cirrhosis Christine Bernsmeier, Basel
1400 - 1410 Ballsaal	Intratumor heterogeneity is conserved in single cell-derived hepatocellular carcinoma organoids Lukas Kübler, Basel
1410 - 1420 Ballsaal	Immune landscaping of Mc4rKO livers unveils immunosuppressive cell composition in hepatic crown-like structures in MASH Fabienne Birrer, Bern
1420 - 1430 Ballsaal	Assessment of hypervolemia using compression pressure of the external jugular vein in decompensated liver cirrhosis during passive leg raise and albumin infusion Daniel Segna, Bern
1430 - 1440 Ballsaal	Selective Targeting Of The Blood-Biliary Barrier Ameliorates Fibrotic and Cholestatic Liver Damage by Enhancing Bicarbonate Secretion and Bile Dynamics. Felix Baier, Bern
1440 - 1450 Ballsaal	Efficacy and Safety of Bulevirtide in Patients with Chronic Hepatitis D Treated under Early Access in Switzerland Mirjam Kolev, Bern
1450 - 1500 Ballsaal	Antimicrobial Stewardship Significantly Improved The Antibiotic Appropriateness And Clinical Outcomes In Patients With Decompensated Cirrhosis At A Tertiary Care Center In Switzerland Yuly Mendoza, Bern
1330 - 1500 Saal Brünig	SGVC session II: State of the Art Upper GI - benign disease Andrea Donadini, Lugano    Valentine Luzuy-Guarnero, Genève
1330 - 1352 Saal Brünig	Functional upper GI-Disorders: what a surgeon needs to know Mark Fox, Arlesheim
1352 - 1414 Saal Brünig	GERD and Hiatal Hernia- Surgery how and for whom? Lana Fourie, Luzern
1414 - 1436 Saal Brünig	Obesity Surgery-when to perform which surgery? Patrick Folie, St. Gallen
1436 - 1500 Saal Brünig	Upper GI Tumors other than carcinomas and their treatment Marcel-André Schneider, Zürich
1500 - 1530 Exhibition Area	Coffee break
1500 - 1530 Kongresssaal (Exhibition Area)	Guided Poster Walks Gastroenterology, Hepatology, Surgery
1530 - 1700 Auditorium	Endsoscopy II - ERCP: meet the experts [sponsored by Cook, DesoMedical, Olympus] (simultaneous interpreting into german, french and italian) Lukas Degen, Basel    Ines Friebe, Aarau    Christoph Schlag, Zürich
1530 - 1610 Auditorium	Case 1 Mariola Marx, Lausanne    Jonas Hiller, Lausanne
1610 - 1650 Auditorium	Case 2 Gian-Marco Semadeni and Nursing Team from H-OCH, St. Gallen
1410 - 1420 Theatersaal	Acceptability and Tolerance of Risankizumab Treatment Administered via On-Body Injector in Patients with Crohn’s Disease: Results of the Nationwide ACCEPT-OBI Study Pascal Juillerat, Bern and Fribourg
1530 - 1700 Theatersaal	Endoscopy oral presentations Patrick Aepli, Luzern    Kaspar Truninger, Zürich
1530 - 1555 Theatersaal	Celiac disease: what the clinician should know in 2025 Jorunn Stamnaes, Oslo
1600 - 1610 Theatersaal	Peroral Endoscopic Myotomy (POEM) for treatment of achalasia: Results from a Single-Center Prospective Study of 233 Patients at a Swiss Tertiary Referral Hospital Giorgi Tvaradze, Zurich
1610 - 1620 Theatersaal	Prospective Evaluation of Traction-Assisted Closure with Tissue Inverted Clipping Strategy (TACTICS)-Assisted EFTR for Gastric GIST: A Single-Center Study of a Novel Full-Thickness Resection and Closure Technique Giorgi Tvaradze, Zurich
1620 - 1630 Theatersaal	Endoscopic ultrasound-guided hepato-portal sampling in morbidly obese patients with metabolic dysfunction-associated fatty liver disease (MAFLD): pilot-trial for metabolic research and biomarker assessment. Study Protocol Riad Sarraj, Bern
1630 - 1640 Theatersaal	Practices and Perspectives on Prophylactic Pancreatic Stent Placement: The PIRATE Survey Marius Zimmerli, Basel
1640 - 1650 Theatersaal	Endoscopic remission prevents development of complicated disease course in eosinophilic esophagitis patients Anne Godat, St. Gallen
1650 - 1700 Theatersaal	Quality indicators of EUS-guided liver biopsy: A single-centre experience Hartmut Steinle, Liestal
1530 - 1700 Ballsaal	Swiss Expert Opinion Statements (EOS) Jan Borovicka, St. Gallen    Daniele Riva, Lugano
1530 - 1552 Ballsaal	Antibiotic prophylaxis in GI endoscopy Remus Frei, St. Gallen
1552 - 1614 Ballsaal	Screening, diagnosis and treatment of metabolic dysfunction-associated liver disease (MASLD) Nicolas Goossens, Genève
1614 - 1636 Ballsaal	Liver biopsy David Semela, St. Gallen
1636 - 1700 Ballsaal	Management of alveolar echinoccocosis Ansgar Deibel, Zürich
1530 - 1700 Saal Brünig	SGVC session III: State of the art Upper GI – malignant disease Antonio Nocito, Baden    Diana Vetter, Zürich
1530 - 1600 Saal Brünig	Management of premalignant disease and early cancer Christoph Gubler, Zürich
1600 - 1630 Saal Brünig	Management of Esophageal Cancer Mickaël Chevallay, Genève
1630 - 1700 Saal Brünig	Management of Gastric- and GEJ-Cancer Yves Borbély, Bern
1715 - 1815 Auditorium	General Assembly SVEP-ASPE
1715 - 1815 Theatersaal	General Assembly Swiss Society of Gastroenterology SGGSSG
1715 - 1815 Saal Brünig	General Assembly Swiss Visceral Surgeons SGVC
1815 - 1915 Auditorium	General Assembly IBDnet
1815 - 1915 Theatersaal	General Assembly SASL
1815 - 1915 Ballsaal	General Assembly MDL
1815 - 1915 Saal Harder 1+2	General Assembly Swiss NGM

Friday, 12.9.2025

0745 - 0815 Theatersaal	Early-Bird-Symposium Dr. Falk Pharma AG
0745 - 0815 Ballsaal	Early-Bird-Symposium Erbe Swiss AG
0830 - 1000 Auditorium	Endoscopy III - IBD: meet the experts [sponsored by BMS, IQone, Johnson&Johnson, Sandoz Pharmaceuticals, Takeda Pharma] (simultaneous interpreting into german, french and italian) Stephan Brand, St. Gallen    Petr Hruz, Basel    Elisabeth Winkler, Wien, Austria
0830 - 0900 Auditorium	Extraintestinal manifestations of IBD Stephan R. Vavricka, Zürich
0900 - 0930 Auditorium	The experience of transition of young adults with IBD to adult medicine Ursina Biss, Zürich
0930 - 1000 Auditorium	Case presentation Emanuel Burri, Liestal    Claudia Bieger, Liestal
0830 - 1000 Theatersaal	EoE Update [sponsored by Sanofi-Aventis] Alain Schoepfer, Lausanne    Alex Straumann, Zürich
0830 - 0900 Theatersaal	Updated European EoE guidelines 2025: what has changed? Thomas Greuter, Lugano
0900 - 0930 Theatersaal	Targeted therapies in EoE Luc Biedermann, Zürich
0930 - 1000 Theatersaal	Diets in EoE: do they work? Alfredo J Lucendo, Tomelloso
0830 - 1000 Ballsaal	Hepatology Hot Topics 2025 Annalisa Berzigotti, Bern    David Semela, St. Gallen
0830 - 0852 Ballsaal	Present and future of immunotherapies in the management of HCC Josep M. Llovet, Barcelona
0852 - 0914 Ballsaal	Pharmacological treatment of portal hypertension: NSBB and beyond Jaime Bosch, Bern
0914 - 0936 Ballsaal	State of the art: transjugular intrahepatic portosystemic shunt (TIPS) Virginia Hernández-Gea, Barcelona
0936 - 1000 Ballsaal	Viral Hepatitis: update 2025 Beat Müllhaupt, Zürich
0830 - 1000 Saal Brünig	SGVC Rapid fire answers to hot topics Beat Schnüriger, Bern    Markus Weber, Zürich
0830 - 0842 Saal Brünig	Does FLOT beat CROSS for adenocarcinoma of the esophagogastric junction? Ralph Fritsch, Zürich
0842 - 0854 Saal Brünig	Role of limited gastric resections in gastric cancer Styliani Mantziari, Lausanne
0854 - 0906 Saal Brünig	What’s the role of laparoscopic colon surgery in the robotic era? Martin Bolli, Luzern
0906 - 0918 Saal Brünig	Should we aim for partial adrenalectomies? Corina Kim-Fuchs, Bern
0918 - 0930 Saal Brünig	When is the time for sternotomy in retrosternal goiters? Frédéric Triponez, Genève
0930 - 0942 Saal Brünig	Immunotoxicities: highlights for the surgeon Assma Ben Aissa, Genève
0942 - 0956 Saal Brünig	When to do transplant in colorectal liver metastases? Henrik Petrowsky, Zürich
0830 - 1000 Saal Grimsel 1 + 2	Workshop TARDOC (german) Urs Stoffel, Zürich    Ellen Utzinger, Wallisellen
0830 - 1000 Saal Harder 1+2	Workshop TARDOC (french) Sophie Buyse, Yverdon    Alain Vonlaufen, Genève
1000 - 1030 Exhibition Area	Coffee break
1030 - 1200 Auditorium	SGG-SGVC-SASL-SVEP Joint Session - Controversies in Gastric Cancer Management and 3 Prize Winner Talks (simultaneous interpreting into german, french and italian) Andrew Macpherson, Bern    Markus K. Müller, Frauenfeld    David Semela, St. Gallen    Alain Vonlaufen, Genève
1030 - 1050 Auditorium	Intestinal Metaplasia Simon Leedham, Oxford
1050 - 0110 Auditorium	Pros and Cons for ESD and EMR in gastric cancer Peter Bauerfeind, Luzern
1110 - 1130 Auditorium	Controversies in gastric cancer surgery Stefan Mönig, Genève
1130 - 1200 Auditorium	Prizewinner Talks
1200 - 1330 Exhibition Area	Lunch break
1230 - 1330 Saal Susten	GA Arbeitgemeinschaft für Endokrine Chirurgie – AGEC/GTCE
1215 - 1245 Ballsaal	Lunch symposium Eli Lilly
1215 - 1245 Theatersaal	Lunch symposium Takeda
1250 - 1320 Ballsaal	Lunch symposium Pfizer: Velsipity in Practice: Ask the Experts Luc Biedermann, Zürich    Thomas Greuter, Lugano    Robert Hoepner, Bern
1250 - 1320 Theatersaal	Lunch symposium Johnson&Johnson: Breaking Barriers: Advancing IBD Treatment through Innovative: Therapies and Safety Insights Stephan Brand, St. Gallen    Pascal Juillerat, Bern, Fribourg    Frank Seibold, Bern
1330 - 1500 Auditorium	Nursing profiles in interprofessional teams (simultaneous interpreting into german, french and italian) Frank Bieger, Oberwil    Patrizia Künzler-Heule, St. Gallen
1330 - 1400 Auditorium	Keynote: Delivering quality care – the integral role of the liver nurse Michelle Clayton, Leeds
1400 - 1410 Auditorium	Swiss landscape of nursing roles Sonja Beckmann, Zürich
1410 - 1420 Auditorium	Study nursing in gastroenterology and hepatology Kelly Da Silva, Basel
1420 - 1430 Auditorium	IBD nurse Dritë Rushiti, Chur
1430 - 1440 Auditorium	Transplant Coordinator Nasila Chappuis, Lausanne
1440 - 1450 Auditorium	APN Hepatology Patrizia Künzler-Heule, St. Gallen
1450 - 1500 Auditorium	Discussion
1330 - 1500 Theatersaal	Gastroenterology oral presentations Jean-Louis Frossard, Genève    Jan Hendrik Niess, Basel
1330 - 1355 Theatersaal	GI effects of GLP1 agonists Lucie Favre, Lausanne
1400 - 1410 Theatersaal	Eosinophil subset dynamics and transcriptional signatures in colorectal cancer progression Glenn De Lange, Zurich
1410 - 1420 Theatersaal	Rising Incidence of Helicobacter pylori Antibiotic Resistance in Eastern Switzerland: HARRiS Trial – An Interim Analysis Alexander Kueres-Wiese, St. Gallen
1420 - 1430 Theatersaal	Cyp2s1-dependent modulation of the intestinal metabolome and microbiome Sara Dylgjeri, Basel
1430 - 1440 Theatersaal	A2 beta casein milk and its impact on histological disease activity and on in-vitro models of eosinophilic esophagitis Emilie Gueguen, Zurich
1440 - 1450 Theatersaal	A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation Manuel Jakob, Bern
1450 - 1500 Theatersaal	Establishing Reference Intervals for Area Under the Curve and Slope in Gastric Emptying Scintigraphy using the Mixed Nottingham Test Meal Matteo Piazza, Bern
1330 - 1500 Ballsaal	Hepatology oral presentations II Nicolas Goossens, Genève    Anja Lachenmayer, Bern
1330 - 1355 Ballsaal	The skin-neuron-axis in cholestatic pruritus Andreas Kremer, Zürich
1400 - 1410 Ballsaal	Validation of Lille Model at day 4 in patients with severe alcoholic hepatitis Nicolas Conquet, Geneva
1410 - 1420 Ballsaal	Monocyte Distribution Width as a Novel Biomarker for Assessing Disease Severity in Liver Cirrhosis Lukas Jutzi, Basel
1420 - 1430 Ballsaal	MAIT cell depletion and dysfunction in patients with portal hypertension undergoing TIPSS Josias Mürle, Basel
1430 - 1440 Ballsaal	Impact of Loss of PCSK9 Expression in Hepatocytes Ainhoa Asensio Aldave, Bern
1440 - 1450 Ballsaal	A HEV ORF2 protein-mediated mechanism of hepatitis E-associated kidney disease Anne-Laure Leblond, Zurich
1450 - 1500 Ballsaal	Post-Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors, and Outcomes in Patients with Cirrhosis Maria de Brito Nunes De Brito Nunes, Bern
1330 - 1500 Saal Brünig	SGVC Largiadèr Session Guido Beldi, Bern    Markus K. Müller, Frauenfeld
1330 - 1340 Saal Brünig	Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer Raffaello Roesel, Lugano
1340 - 1350 Saal Brünig	Modelling cell–cell communication reveals progranulin as a driver of liver regeneration Daniel Sanchez-Taltavull, Bern
1350 - 1400 Saal Brünig	Recipient donor sex combination association with infections after solid organ transplantation – A Swiss Transplant Cohort Study Christian Magyar, Bern
1400 - 1410 Saal Brünig	Peritoneal Macrophage-Derived Plasma Fibronectin Enhances Remote Skin Wound Healing Lilian Salm, Bern
1410 - 1420 Saal Brünig	Machine learning models to predict hepatocellular carcinoma recurrence after liver transplantation Daniel Sanchez-Taltavull, Bern
1420 - 1430 Saal Brünig	RNF43-mutations are associated with the classical molecular subtype, vigorous antitumor immune responses and prolonged survival in pancreatic cancer Anna Silvia Wenning, Bern
1430 - 1440 Saal Brünig	Beyond P-Values: Novel Minimal Important Difference of the Comprehensive Complication Index (CCI®) that reflects a Meaningful Outcome for Patients Undergoing Major Abdominal Surgery Fariba Abbassi, Zurich
1440 - 1450 Saal Brünig	Novel Benchmarks for Robotic Whipple Surgery Matthias Pfister, Zurich
1450 - 1500 Saal Brünig	New score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation offers better performance than RETREAT or RELAPSE Severin Gloor, Bern
1330 - 1500 Saal Grimsel 1 + 2	Workshop TARDOC (german) Urs Stoffel, Zürich    Ellen Utzinger, Wallisellen
1330 - 1500 Saal Harder 1+2	Workshop TARDOC (french) Sophie Buyse, Yverdon    Alain Vonlaufen, Genève
1500 - 1530 Exhibition Area	Coffee break
1530 - 1700 Auditorium	Tour de Suisse - Tips and tricks for daily clinical practice (simultaneous interpreting into german, french and italian) Sophie Buyse, Yverdon    Andrea De Gottardi, Luzern    Pascal Juillerat, Bern, Fribourg
1530 - 1540 Auditorium	How do I treat IBS? Daniel Pohl, Zürich
1540 - 1550 Auditorium	How do I treat MASLD in 2025? David Semela, St. Gallen
1550 - 1600 Auditorium	How do I work up chronic diarrhea? Alain Schoepfer, Lausanne
1600 - 1610 Auditorium	How do I treat portal hypertension? Andrea De Gottardi, Luzern
1610 - 1620 Auditorium	How do I diagnose and treat SIBO? Andrew Macpherson, Bern
1620 - 1630 Auditorium	How to I treat chronic hepatitis D? Montserrat Fraga, Lausanne
1630 - 1640 Auditorium	How and when do I perform POEM? Peter Bauerfeind, Luzern
1640 - 1650 Auditorium	How do I surveille Barrett\'s esophagus? Marius Zimmerli, Basel
1530 - 1700 Theatersaal	Young Gastroenterologists: Parachute Interlaken. My parachute for the exam and clinical practice Daniele Riva, Lugano    Sena Blümel, Zürich
1530 - 1552 Theatersaal	How to prep and slay the exam Manuel Lehner, Basel
1552 - 1614 Theatersaal	Nutrition - the dirty basics for the European Board Marius König, St. Gallen
1614 - 1636 Theatersaal	Non Variceal Bleeding – what`s in the Guidelines Costanza De Maria, Lugano
1636 - 1700 Theatersaal	Fatty Liver and all its friends – what to know Sena Blümel, Zürich
1500 - 1700 Ballsaal	Abdominal Sonography Course (SGUM: 2 Credits) Isabelle Panne, Basel    Pamela Meyer-Herbon, St. Gallen
1530 - 1700 Saal Brünig	SGVC surgery oral presentations Fariba Abbassi, Zürich    Diego De Lorenzi, Grabs
1530 - 1540 Saal Brünig	Beyond MRI: using CEUS to increase the diagnostic accuracy of liver lesions in patients with pancreatic cancer Stephanie Perrodin, Bern
1540 - 1550 Saal Brünig	Global Benchmarks for Minimally Invasive Right Hemicolectomy for Adenocarcinoma Fariba Abbassi, Zurich
1550 - 1600 Saal Brünig	Evidence Map of Colonic Diverticulitis – A Living Systematic Review with Meta-Analyses Nicola Schaffner, Frauenfeld
1600 - 1610 Saal Brünig	Vacuum-assisted self-expanding stents – early experiences with a novel tool to prevent and treat colorectal anastomotic leakages Michaela Ramser, Zurich
1610 - 1620 Saal Brünig	Preoperative Vascular Mapping for Complete Mesocolic Excision During Right Colectomy; a Single Center Feasibility Study Nelly Gauderon, Villars-sur-Glâne
1620 - 1630 Saal Brünig	Meta-Analysis of Corticosteroids in Pancreatic Surgery Katarzyna Czuj, Münsterlingen
1630 - 1640 Saal Brünig	Impact of fluorescence angiography on anastomotic leak and complication rates after colorectal surgery: a systematic review and meta-analysis of randomized controlled trials Alexandre Balaphas, Geneva
1640 - 1650 Saal Brünig	First experiences with the daVinci SP system in abdominal surgery in Switzerland Diana Daume, Lucerne
1650 - 1700 Saal Brünig	Immunonutrition in Minimally Invasive Major Abdominal Surgery Matthias Pfister, Frauenfeld

---

Posters

Posters

Gastroenterology

Gastroenterology 1	Sustained Corticosteroid-Sparing Effects of Upadacitinib Maintenance Therapy in Patients With Moderate-to-Severe Crohn’s Disease: 2-Year Results From the U-ENDURE Long-Term Extension Study Vipul Jairath1, Marla C. Dubinsky2, Luc Biedermann3, Toshimitsu Fujii4, Colla Cunneen5, Elena Dubcenco5, Sharanya Ford5, Andrew Garrison5, Edward V. Loftus Jr6\r\n1Department of Medicine, Western University, London, ON, Canada; 2Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; 4Institute of Science Tokyo, Tokyo, Japan; 5AbbVie Inc, North Chicago, IL, USA; 6Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA University Hospital Zurich
Gastroenterology 2	Swiss cantonal hospital experience in endoscopic submucosal dissection for colorectal lesions Thomas Balanis, Radu Tutuian Bürgerspital Solothurn
Gastroenterology 3	Effective Management of Esophageal Variceal Hemorrhage Complicated by Ulcerative Reflux Esophagitis Using Over-the-Scope Clip (OTSC) Following Failed Band Ligation: A Case Report Thomas Balanis, Brindusa Diaconu, Radu Tutuian, Felix Brunner Bürgerspital Solothurn
Gastroenterology 4	Single-Session Endoscopic Ultrasound-Directed Transgastric ERCP: A Case Report Riad Sarraj, Laura Witschi, Tharshika Vasanthan, Reiner Wiest Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital Bern
Gastroenterology 5	Use of Resuscitative Endovascular Balloon Occlusion (REBOA) to Facilitate Hemostasis in a Massive Gastrointestinal Hemorrhage – A Case Report Jonas Brunner, Riad Sarraj, Reiner Wiest, Wolf Hautz 1. Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital Bern \r\n2. Universitätsklinik für Notfallmedizin, Inselspital Bern
Gastroenterology 6	Update 2025 on the Swiss Eosinophilic Esophagitis Cohort Jeanine Wakim1, Catherine Saner1, Ekaterina Safroneeva2, Jean-Benoit Rossel2, Emanuel Burri3, Patrick Aepli4, Annett Franke5, Luc Biedermann6, Thomas Greuter1,7, Peter Netzer8, Alex Straumann6, SEECS group, Alain Schoepfer1 1CHUV, Lausanne, 2ISPM Bern, 3US Baselland, 4KS Luzern, 5KS St. Gallen, 6US Zuerich, 7Spital Wetzikon, 8GastroZentrum Bern
Gastroenterology 7	Dupilumab Results in Clinically Meaningful Improvements in Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis: Post-hoc Analysis of LIBERTY EoE TREET Kathryn Peterson, Evan Dellon, Francesca Racca, Alain Schoepfer*, Changming Xia, Sherif Zaghloul, Bram P. Raphael, Sarette T. Tilton, Thomas R Service de gastro-entérologie et d\'hépatologie\r\nCHUV\r\nRue du Bugnon 44\r\n1011 Lausanne, Suisse
Gastroenterology 8	Dupilumab Normalizes Key Histopathologic Features of Eosinophilic Esophagitis: Post Hoc Analysis of the Phase 3 LIBERTY EoE TREET Study Margaret H. Collins, Nirmala Gonsalves, Dhandapani Ashok, Kevin O. Turner, Christoph Schlag*, Changming Xia, Sherif Zaghloul, Bram P. Raphael, James T. Angello, Amr Radwan University Hospital Zurich, Raemistrasse, Zurich, Switzerland
Gastroenterology 9	Impact of Reprocessing Steps on Microbial Load of Colonoscopes Jürg Wermuth, Stefanie Kasal Private Praxis
Gastroenterology 10	Dupilumab Led to Rapid and Sustained Improvement in Dysphagia in Patients With Eosinophilic Esophagitis After Switching From Placebo: Results From Part C Of The Liberty EoE TREET Study Evan S. Dellon, Mirna Chehade, Albert J. Bredenoord, Jonathan M. Spergel, Jeanine Wakim*, Changming Xia, Sarette T. Tilton, Eilish McCann, B Raphael, Juby A. Jacob-Nara, Amr Radwan Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland
Gastroenterology 11	Upadacitinib improves symptomatic, biochemical, and sonographic parameters in active UC patients up to one year after treatment induction – one year interim results from the IBD-DACH study EUROPE Sebastian Zeissig 1, Renate Schmelz 2, Ulf Helwig 3#, Alexander R Moschen 4, Thomas Greuter 5, Imma Fischer 6, Leonie Hammer 7, Stefan Rath 7, Torsten Kucharzik 8, Christian Maaser 9 1Clinic and Polyclinic for Internal Medicine A, Greifswald University Medical Center, Germany; 2Department of Medicine I University Hospital Carl Gustav Carus Dresden of Technische Universität (TU) Dresden, Germany; 3Gastroenterology Practice, Oldenburg, Germany; #University of Kiel, Kiel, Germany; 4Department of Internal Medicine 2, Johannes Kepler University of Linz, Austria; 5Department of Gastroenterology, EOC Lugano, Switzerland; 6Biostatistik-Tuebingen, Tuebingen, Germany; 7Medical Department, AbbVie Germany GmbH & Co.KG, Wiesbaden, Germany; 8Department of Internal Medicine and Gastroenterology, University Teaching Hospital Lueneburg, Lueneburg, Germany; 9Outpatients Department Gastroenterology, University Teaching Hospital Lueneburg, Lueneburg, Germany
Gastroenterology 12	Effectiveness and Safety of Mirikizumab after switching from Ustekinumab in Patients with Moderate-to-Severe Crohn’s Disease: Results from a Long-Term Extension Study Geert D\'Haens1, David Laharie2,3, Parambir S. Dulai4, Frank Seibold (Presenter)5, Britta Siegmund6, Bincy Abraham7,8,9, Lisa Malter10, Marijana Protic11, Nathan Morris11, Rebecca R. Hozak11, Richard E. Moses11, Michelle Ugolini Lopes11, Frederick Durand11, Guanglei Yu11, Severine Vermeire12 1Crohn-Colitis Zentrum, Intesto, Lindenhofspital, Bern, Switzerland\r\n2Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, Netherlands\r\n3CHU de Bordeaux, Hôpital Haut-Lévêque, Service d\'Hépato-Gastroentérologie, Bordeaux, France\r\n4Oncologie Digestive, Université de ordeaux, Bordeaux, France\r\n5Division of Gastroenterology, University of California, San Diego, CA, USA\r\n6Division of Gastroenterology, Infectiology and Rheumatology, Medical Department, Charité–Universitätsmedizin, Berlin, Germany\r\n7Houston Methodist Gastroenterology Associates, Houston, TX, USA\r\n8Weill Cornell Medical College, New York, NY, USA\r\n9Houston Methodist Academic Institute, Houston, TX, USA\r\n10 Division of Gastroenterology, Department of Medicine NYU Langone Health, New York, NY, USA\r\n11Eli Lilly and Company, Indianapolis, IN, USA\r\n12Department of Gastroenterology and Hepatology, Department of Chronic Diseases and Metabolism, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Gastroenterology 13	Rapunzel Syndrome – a rare cause of recurrent vomiting and weight loss Roger Scherer, Nadine Stanek, Simon Bütikofer Luzerner Kantonsspital
Gastroenterology 14	Impact of Mirikizumab on Extraintestinal Manifestations of Crohn’s Disease in the VIVID-1 Study Stephan Vavricka (Presenter)1, Ashwin Ananthakrishnan2, Millie Long3, Gil Y. Melmed4, Neeraj Narula5, David Rubin6, Emily Hon7, Hilde Carlier7, Richard Moses7, Guanglei Yu7, Huaiyu Zang7, Torsten Kucharzik8 1Triemli Hospital, Zurich, Switzerland; 2Harvard Medical School, Boston, MA, USA; 3University of North Carolina School of Medicine, Chapel Hill, NC, USA; 4Cedars Sinai, Los Angeles, CA, USA; 5McMaster University, Hamilton, ON, Canada; 6University of Chicago Medicine, Chicago, IL, USA; 7Eli Lilly and Company, Indianapolis, USA; 8Municipal Hospital of Lüneburg, Lüneburg, Germany
Gastroenterology 15	Infliximab in a case of refractory non-Crohn’s disease complex fistula system – pure desperation or successful ultima ratio? Nada Agbariah, Matthias Kis, Christine Manser, Luc Biedermann, Gerhard Rogler Division of Gastroenterology and Hepatology, University Hospital of Zurich, Switzerland - Division of Gastroenterology, Kantonsspital Frauenfeld, Switzerland
Gastroenterology 16	Does pickled food consumption increase the risk of oesophageal cancer – a systematic review with a meta-analysis, adjusted for a single reviewer Viktoria V. Voller 1, Sascha A. Müller2, Bernhard Voller 3, Daniel Gallacher 4, Felix Stickel2 1. Department of General Surgery, North Lincolnshire and Goole Foundation Trust NHS, Scunthorpe General Hospital, UK\r\n2. VISCERA Abdominal Medicine, Bern and Division of Gastroenterology and Hepatology, University Hospital Zurich\r\n3. Neurozentrum Bern, Bern, Switzerland\r\n4. Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
Gastroenterology 17	Not Every Gallop Is a Horse: A Rare Case of Colorectal Cancer \r\nin Pregnancy Tabea Pfister, Riad Sarraj, Reiner Wiest Department of Visceral Medicine and Surgery, University Hospital Bern
Gastroenterology 18	Risankizumab Real World Experience in Switzerland: Report on 130 Patients with Crohn’s Disease from 3 IBD centers. Pascal Juillerat* (1,2,3), Roseline Ruetsch, (2), Luis Salvador Nunes (2), Landry Hakiza (1), Laura Rossier (1,4), Nico weber (1), Andrea Raaflaub (1), Samuel Nyffeler (1), Christelle Margot (1), Anne-Sophie Jasawant (1), Sarah Mirjam Bott (1), Micaela Tobler (1), Camelia Anghilina (1), Georgiana Tutuian (1), Etienne Gfeller (1), Konstantin Burgmann (1), Dominique Staudenmann (1), Cyrille Frei (1), Christophe Matter (1) and Frank Seibold (1). (1) Gastroenterology, Intesto KLG, Bern and Fribourg. (2) Gastroenterology center, Bulle. (3) Clinic for Visceral Surgery and Medicine, Bern University Hospital, Inselspital (4) Gastroenterology and Hepatology, CHUV, Lausanne.
Gastroenterology 19	Feasability of ESD training on ex-vivo animal model in a single university hospital: report of first procedures Finci Léon, Lepilliez Vincent, Bichard Philippe, Frossard Jean-Louis Division of Gastroenterology and Hepatology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211 Genève \r\nHépato-Gastro-Entérologie, Hôpital Privé Jean Mermoz, Lyon, France
Gastroenterology 20	Harmonizing Gastroenterology Training: An Analysis of European Curricula in the United European Gastroenterology Sophie Schlosser 1, Jonas Staudacher 2, Verena Wagner 3, Mira Unger 3, Paula Sousa 4, Inga Marie Donning 3, Martina Müller-Schilling 1, Henriette Heinrich 5 on behalf of the GENIUS Study Group (National Societies Forum, National Societies Committee, Young Talent Group & Friends) 1) Medizinische Klinik 1, Gastroenterologie und Hepatologie, Universität Regensburg\r\n2) Abteilung für Gastroenterologie und Hepatologie, Charite Universitätsmedizin Berlin, Deutschland\r\n3) UEG Education \r\n4) Centro Hospitalar Tondela – Viseu, EPE, Viseu, Portugal\r\n5) Clarunis Universitäres Bauchzentrum, Gastroenterologie und Hepatologie, Basel, Schweiz
Gastroenterology 21	Pancreatic polypeptide family secretion in healthy, lean \r\nindividuals during an endoscopic luminal fat and short-term lowcarbohydrate high-fat diet challenges Tabea Pfister, Elija Beutler, Philippe Eugster, Abid Karim Alexandre, Eric Gouszmann, Mojgan Masoodi, Lia Bally, Reiner Wiest Department of Visceral Medicine and Surgery, Inselspital and \r\nUniversity of Bern \r\nDepartment of Pharmacology, Centre Hospitalier Universitaire Vaudois, Lausanne\r\nDepartment of Clinical Chemistry, Inselspital und University of Bern\r\nDepartment of Diabetes and Endocrinology Nutritional Medicine and Metabolism, Inselspital and University of Bern
Gastroenterology 22	Improvement in Fatigue with Mirikizumab Therapy and Associations with Clinical Outcomes in Patients with Moderately-to-Severely Active Crohn’s Disease: Results from the PHASE 3 VIVID-1 Study Peter Bossuyt,1 Miguel Regueiro,2 Monika Fisher,3 Kristina Traxler,4 Guanglei Yu,4 Marijana Nedeljkovic Protic,4 Konstantinos Tsilkos,4 Aisha Vadhariya,4 Tadakazu Hisamatsu,5 Pascal Juillerat (Presenter)6 1Imelda GI Clinical Research Center, Imelda General Hospital, Bonheiden, Belgium; 2Cleveland Clinic, Cleveland, OH, USA; 3Indiana University, Indianapolis, IN, USA; 4Eli Lilly and Company, Indianapolis, IN, USA; 5Kyorin University School of Medicine, Tokyo, Japan; 6Intesto Crohn\'s and Colitis Center, Bern and Fribourg, Switzerland

Hepatology

Hepatology 1	Use of Maralixibat for treatment-resistant pruritus in intrahepatic cholestasis of pregnancy: A case report Lara Alexandra Bersuch, Andrea De Gottardi Department of Gastroenterology and Hepatology, Cantonal Hospital Lucerne, Switzerland
Hepatology 2	Feasibility, safety and effectiveness of Transjugular liver \r\nbiopsy with previously placed transjugular intrahepatic \r\nportosystemic shunt : a case series Lucas Ramer, Jérémy Hassoun, Clémence M Canivet, Nicolas \r\nGoossens, Laurent Spahr Hôpitaux Universitaires de Genève
Hepatology 3	DNA Replication Stress in MASH Ainhoa Asensio Aldave, Daniel Sanchez-Taltavull, Fabienne Birrer, Vasilis S. Dionellis, Giacomo G. Rossetti, Angeliki Karamichali, Adrian Keogh, Daniel Candinas, Thanos D. Halazonetis & Deborah Stroka 1. Department of Visceral Surgery and Medicine, University of Bern, Inselspital, Bern University Hospital, Bern\r\n2. Department of Molecular Biology, University of Geneva, Geneva.
Hepatology 4	The changing pattern of liver related specialist consultations in Southern Switzerland between 2009 and 2024 Barda Beatrice1, De Luca Chiara1, Bissig Maurizia1, Cerny Andreas1\r\n1 Epatocentro Ticino, Lugano, Switzerland Fondazione Epatocentro Lugano
Hepatology 5	Ursodeoxycholic acid response in the Swiss Primary Biliary Cholangitis Cohort Study Dominic Jaminet, Magdalena Filipowicz Sinnreich, Andreas E. Kremer, Andrea De Gottardi, Guido Stirnimann, Christine Bernsmeier, Björn Becker, David Semela, Giulia Magini9, Andreas Cerny, Benedetta Terziroli Beretta-Piccoli Università della Svizzera Italiana, Lugano; Department of Gastroenterology and Hepatology, Basel University Medical Clinic, Cantonal Hospital Baselland, Liestal; Department of Gastroenterology and Hepatology, University Hospital Zurich; Department of Gastroenterology and Hepatology, Cantonal Hospital Luzern, Luzern; Department of Gastroenterology and Hepatology, Inselspital Bern, Bern; University Centre for Gastrointestinal and Liver Diseases, Basel; Department of Gastroenterology and Hepatology, Cantonal Hospital Winterthur, Winterthur; Department of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, St. Gallen; Department of Gastroenterology and Hepatology, University Hospital Geneva, Geneva; Epatocentro Ticino, Lugano; Department of Gastroenterology and Hepatology, Ospedale Civico, Lugano. All in Switzerland.
Hepatology 6	Treatment-Resistant Pruritus in Secondary Sclerosing Cholangitis: Marked Symptom Improvement with Maralixibat – A Case Report Johannes Hofelich (1), Roman Stillhard (1), David Semela (1) (1) Klinik für Gastroenterologie und Hepatologie, HOCH Health Ostschweiz, St. Gallen
Hepatology 7	Effect of liver cholestasis on inflammatory stressors in the intestine Teresa De Enrique Schmitd1,2, Simone De Brot3, Ziad Al Nabhani1, Daniel Candinas1 and Deborah Stroka1 1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern 2Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern 3COMPATH, Institute of Animal Pathology, University of Bern, Bern
Hepatology 8	Planned Treatment of Chronic Hepatitis C Virus Infection During Pregnancy: First Reported Case in Switzerland Sarah Zwyssig1, Patrizia Künzler-Heule1, Stephan Brand1, Katharina Putora2, Christian Kahlert3, Andreas Malzacher2, David Semela1 1Klinik für Gastroenterologie und Hepatologie, HOCH Health Ostschweiz, St. Gallen\r\n2Klinik für Gynäkologie und Geburtshilfe, HOCH Health Ostschweiz, St. Gallen\r\n3Klinik für Infektiologie, Infektionsprävention und Reisemedizin, HOCH Health Ostschweiz und Ostschweizer Kinderspital, St. Gallen
Hepatology 9	Intracavitary Antibiotic Instillation for Refractory Liver Abscess: Proof of Principle Irina Bergamin (1), Pamela Meyer-Herbon (1), Philipp Kohler (2), Baharak Babouee Flury (2), Stefan Kuster (2), Stephan Brand (1), David Semela (1) (1) Klinik für Gastroenterologie und Hepatologie, HOCH Health Ostschweiz, St. Gallen\r\n(2) Klinik für Infektiologie, Infektionsprävention und Reisemedizin, HOCH Health Ostschweiz, St. Gallen
Hepatology 10	Chronic Hepatitis E in Immunocompromised Patients: A Case Series with Diverse Presentations and Therapeutic Challenges Irina Bergamin (1), Pamela Meyer-Herbon (1), Stephan Brand (1), Marlene Zippl (2), Wolfram Jochum (2), David Semela (1) (1) Klinik für Gastroenterologie und Hepatologie, HOCH Health Ostschweiz, St. Gallen\r\n(2) Institut für Pathologie, HOCH Health Ostschweiz, St. Gallen

Surgery

Surgery 1	Laparoscopic-assisted Pancreatic Necrosectomy (LAPN) In The Treatment Of Walled Off Pancreatic Necrosis: A Retrospective Study Valérie Kremo, Hanna Plazer, Julia Mühlhäusser, Andreas Scheiwiller, Stephan Baumeler, Simon Bütikofer, Jürg Metzger, Martin Bolli, Francesco Mongelli, Jörn-Markus Gass Viszeralchirurgie Luzerner Kantonsspital, Luzern\r\nGastroenterologie Luzerner Kantonsspital, Luzern\r\nViszeralchirurgie, Ospedale Regionale di Bellinzona e Valli, Bellinzona
Surgery 2	ΔWeight is a Predictor of Major Complications After Digestive Surgery Maximilien Ravenel (1, 2), Asaad Khadda (2), Emilie Zhu (1, 2), Laura Didisheim (1, 2), Stéphanie Gonvers (1, 2), David Fuks (1, 2), Fabian Grass (1, 2), Dieter Hahnloser (1, 2), Martin Hübner (1, 2), Gaëtan-Romain Joliat (1, 2), Styliani Mantziari (1, 2), Emmanuel Melloul (1, 2), Markus Schäfer (1, 2), Hugo Teixeira (1, 2), Emilie Uldry (1, 2), Ismail Labgaa (1, 2) 1.Department of Visceral Surgery, Lausanne University Hospital (CHUV), Lausanne, Switzerland).\r\n2.Faculty of Biology & Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland.
Surgery 3	Meta-analysis of intraumbilical versus periumbilical incision in laparoscopic appendectomy Justyna Mohr, Pascal Probst, Pia Antony, Dirk Kleindienst, Fabian Hauswirth, Markus K. Muller, Pietro Renzulli Department of Surgery, Cantonal Hospital Thurgau, Switzerland
Surgery 4	Meta-Analysis of Intraabdominal Drainage After Distal Pancreatectomy Daniel Rodjakovic, Laura Pietrogiovanna, Pia Antony, Fabian Hauswirth, Pietro Renzulli, Markus K. Muller, Pascal Probst Department of Surgery, Cantonal Hospital Thurgau, Switzerland
Surgery 5	Meta-analysis of different techniques for pancreatico-jejunostomy after partial pancreatoduodenectomy Annika Wenzel, Hendrik Strothmann, Pia Antony, Pietro Renzulli, Fabian Hauswirth, Markus K Müller, Pascal Probst Department of Surgery, Cantonal Hospital Thurgau, Switzerland
Surgery 6	Systematic Review of access routes and anastomotic techniques in right hemicolectomy and ileocolic resection Claudius Kessler, Michael Santl, Pascal Probst, Pia Antony, Fabian Hauswirth, Markus K. Muller, Pietro Renzulli Department of Surgery, Cantonal Hospital Thurgau, Switzerland
Surgery 7	Ischemic colitis in an elderly patient with intestinal malrotation: A diagnostic challenge Dr. med. univ. Anna Vermeer, PD Dr. med. Michael Kremer Department of Surgery, Spital Lachen, Lachen SZ, Switzerland
Surgery 8	Machine Learning for detecting Dose Optimization\r\nPotential in Computed Tomography Scans of the Abdomen Daniel Reksten, Johannes Boos, Andrea Steuwe, Benedikt Kamp, Joel Aissa, Christian Rubbert Lucerne Cantonal Hospital, Institute for Radiology and Nuclear Medicine;\r\nDüsseldorf University Hospital, Institute for Radiology
Surgery 9	The first single port robotic gastric wedge resection in Switzerland – a video vignette Diana L. Daume\r\nFlorine Neff\r\nMartin Bolli\r\nLana Fourie Department of Visceral Surgery, Cantonal Hospital of Lucerne, \r\nLucerne, Switzerland
Surgery 10	Impact of patient sex on treatment strategy and long-term survival of esophageal cancer Pauline Curchod (1), Chloé Aeschlimann (2), Sergio Gaspar Figueiredo (1), Hugo Teixeira Farinha (1,2), Clarisse Dromain (2,3), Markus Schäfer (1,2), Styliani Mantziari (1, 2) 1. Department of Visceral Surgery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.\r\n2. Faculty of Biology & Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland.\r\n3. Department of Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland